As previously mentioned, VEGF plays a significant role in the nonimmunological functions of MDSCs, such as inducing the EMT, tumor angiogenesis, and the formation of premetastatic niches, making it a promising therapeutic target for limiting MDSC accumulation and enhancing antitumor immunity. The gene discussed is VEGFA; the disease is neoplasm.